Spring 2015
    Law No.: LAW7694
    Sched. No.: 115210154

New Frontiers in Health Law and Clinical Ethics (SC)
Section 1
X
Bonnie, Richard J.
Chen, Donna T.



Administrative Information:
During SIS enrollment, check on SIS for real-time enrollment numbers
Days, Times (Room):MTWR, 1600-1730 (WB119)
Credits:1Type:Lecture - short course
Capacity:18 **This information is current as of 10/22/2014 06:14:10 AM**
Current Enrollment:0 **This information is current as of 10/22/2014 06:14:10 AM**

Course Description:

This intensive interdisciplinary seminar brings medical students and law students together for two-weeks each spring to explore ethical and legal challenges created by the array of stakeholders who affect, and are affected by, our complex healthcare system and our nation's changing healthcare environment. Through multidisciplinary readings and in-depth discussions across disciplinary boundaries, students will learn how other professionals think and will jointly assess challenges facing tomorrow's healthcare system, exploring various resources available to address these challenges and propose solutions.
Specific topics covered will vary from year to year. In general, we address topical issues at the frontier of clinical care, law, and ethics – some new and others with deep roots that continue to remain at the frontier. Questions we have addressed in previous years include:
Defining death has always been controversial, should we give individuals more say over when they should be considered “dead?”
To what extent should legislatures decide the proper scope of medical practice, displacing the judgment of the profession or of individual practitioners – as exemplified by recent policies affecting physician-assisted suicide?
In the push for evidence-based decision-making, clinical trials using “sham surgery” arms are becoming more common – do the benefits of having information derived from such experiments outweigh the risks of the surgery to the individuals participating in the experiments?
As the population ages and dementia becomes more prevalent, how much weight should be given to choices and preferences expressed by individuals regarding their health care or research participation before they lost their capacity to make these decisions?
Research aimed at understanding and treating memory disorders implicates fundamental notions of personal identity (e.g., we have the ability to “erase” and “implant” memories—but, who are we if not a collection of our good and bad memories?) and cognitive enhancement (e.g., should
physicians prescribe medications that enhance cognition to individuals who do not have a cognitive disorder, but just want that edge?).
And, finally, who gets to decide how we move forward in these areas? Who should be accountable to whom? And, what do the answers say about the future of medicine as a profession?

COURSE REQUIREMENT: TBA